CDC opioid prescribing guideline (2016)
The US Centers for Disease Control and Prevention issued a guideline urging caution on long-term opioids for chronic pain, with dose thresholds doctors were told to justify. States, insurers and pharmacy chains turned the thresholds into hard limits that the guideline had not written.
Prescribing fell sharply. Patients on high doses were tapered quickly or cut off, and pain patients reported withdrawal and untreated pain.
The agency revised the guideline in 2022, removing numerical dose limits and stating that tapering should be individualized and never forced.
The same pattern is in play here: a regulator writes a rule aimed at misuse, and the patients already on the medication absorb the disruption first.
